Skip to main content
. Author manuscript; available in PMC: 2025 Oct 1.
Published in final edited form as: Am J Respir Crit Care Med. 2025 Oct;211(10):1785–1793. doi: 10.1164/rccm.202501-0208OC

Table 1:

Baseline characteristics for the University of Michigan test and the University of Chicago validation cohorts

University of Michigan (n=350) University of Chicago (n=92)
Clinical characteristics
Age, years, mean ± SD 66.3 ± 10.7 64.7 ± 10.9
Male sex, n (%) 184 (52.6) 56 (60.9)
Body mass index (BMI), kg/m2, mean ± SD 30.5 ± 6.5 30.7 ± 7.3
Ever-smoker, n (%) 193 (55.1) 57 (62.0)
Race, n (%)
 White 292 (83.4) 73 (79.3)
 Black 38 (10.9) 13 (14.1)
 Hispanic 5 (1.4) 2 (2.2)
 Asian/Pacific Islander 9 (2.6) 3 (3.3)
 Other/Unknown 6 (1.7) 1 (1.1)
ILD classification, n (%)
 IPF 151 (43.1) 40 (43.5)
 CTD-ILD 118 (33.7) 18 (19.6)
 IIP 53 (15.1) 15 (16.3)
 fHP 28 (8.0) 19 (20.7)
PFT characteristics
Forced vital capacity (FVC), L, mean ± SD 2.6 ± 0.9 2.4 ± 0.8
FVC % predicted, mean ± SD 71.9 ± 19.1 64.2 ± 17.3
Diffusion capacity (DLCO), mm/min/mmHg, mean ± SD 13.0 ± 5.4 10.8 ± 5.8
DLCO % predicted, mean ± SD 54.9 ± 19.2 49.1 ± 19.4
qCT characteristics
Lung volume, L, mean ± SD 3.6 ± 1.2 3.4 ± 1.0
Pulmonary vascular-related structure volume, L, mean ± SD 0.2 ± 0.07 0.2 ± 0.07
% Reticular opacity, mean ± SD 6.4 ± 5.6 6.5 ± 5.2
% Ground glass opacity, mean ± SD 19.0 ± 20.6 24.2 ± 22.5
% Honeycombing, mean ± SD 0.5 ± 1.3 0.2 ± 0.7

Definitions of abbreviations: CTD = connective tissue disease; fHP = fibrotic hypersensitivity pneumonitis; IIP = idiopathic interstitial pneumonia, ILD = interstitial lung disease; IPF = idiopathic pulmonary fibrosis; PFT = pulmonary function test; qCT = quantitative computed tomography